본문으로 건너뛰기
← 뒤로

Experimental Treatment of Measles Encephalitis With Inosine Pranobex and Remdesivir in a Child With Lymphocytic Leukemia.

1/5 보강
Journal of pediatric hematology/oncology 📖 저널 OA 3.3% 2023: 0/2 OA 2024: 0/1 OA 2025: 0/1 OA 2026: 1/26 OA 2023~2026 2026 Vol.48(1) p. e26-e28
Retraction 확인
출처

Cheriyan R, Kumar N, Vijayasekharan K, Rajeshwari B, Reghukumar A, Thankomany P

📝 환자 설명용 한 줄

Measles encephalitis results in devastating epilepsia partialis and/or mortality in the majority of children treated with intense chemotherapy for hematolymphoid malignancies.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Cheriyan R, Kumar N, et al. (2026). Experimental Treatment of Measles Encephalitis With Inosine Pranobex and Remdesivir in a Child With Lymphocytic Leukemia.. Journal of pediatric hematology/oncology, 48(1), e26-e28. https://doi.org/10.1097/MPH.0000000000003141
MLA Cheriyan R, et al.. "Experimental Treatment of Measles Encephalitis With Inosine Pranobex and Remdesivir in a Child With Lymphocytic Leukemia.." Journal of pediatric hematology/oncology, vol. 48, no. 1, 2026, pp. e26-e28.
PMID 41191824 ↗

Abstract

Measles encephalitis results in devastating epilepsia partialis and/or mortality in the majority of children treated with intense chemotherapy for hematolymphoid malignancies. Although many agents have been studied in the treatment of Measles encephalitis with variable results, there are no effective strategies to mitigate the significant morbidity associated with measles encephalitis till date and treatment has remained largely supportive. In this report, a novel combination of antivirals have been shown to abrogate the morbid sequelae of Measles encephalitis with eventual complete recovery in a child with B-acute lymphoblastic leukemia.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반